Clinical Trials Browser

Phase 2 × Oxycodone × 30 days × Clear all

NCT05265052 2026-03-11

3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain

Phase 2 Not yet recruiting

Cancer Pain